GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DuChemBio Co Ltd (XKRX:176750) » Definitions » Capex-to-Revenue

DuChemBio Co (XKRX:176750) Capex-to-Revenue : 0.04 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is DuChemBio Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

DuChemBio Co's Capital Expenditure for the six months ended in Dec. 2023 was ₩-1,297.50 Mil. Its Revenue for the six months ended in Dec. 2023 was ₩34,695.49 Mil.

Hence, DuChemBio Co's Capex-to-Revenue for the six months ended in Dec. 2023 was 0.04.


DuChemBio Co Capex-to-Revenue Historical Data

The historical data trend for DuChemBio Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuChemBio Co Capex-to-Revenue Chart

DuChemBio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial 0.08 0.03 - 0.02 0.04

DuChemBio Co Semi-Annual Data
Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue Get a 7-Day Free Trial 0.08 0.03 - 0.02 0.04

Competitive Comparison of DuChemBio Co's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, DuChemBio Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DuChemBio Co's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DuChemBio Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where DuChemBio Co's Capex-to-Revenue falls into.



DuChemBio Co Capex-to-Revenue Calculation

DuChemBio Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-1297.496) / 34695.49
=0.04

DuChemBio Co's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-1297.496) / 34695.49
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DuChemBio Co  (XKRX:176750) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


DuChemBio Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of DuChemBio Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


DuChemBio Co (XKRX:176750) Business Description

Traded in Other Exchanges
N/A
Address
Daegu 47, Jinyang Building, 4th floor, Chungjeong-ro 2, Gyeonggi, Seoul, KOR, 190-3
DuChemBio Co Ltd is engaged in manufacturing and sale of radiopharmaceuticals and radioactive medicines. It also imports and sells medical equipment related to nuclear medicines.

DuChemBio Co (XKRX:176750) Headlines

No Headlines